Crown Reserve Acquisition Corp. I (NASDAQ: CRAC) is a blank check special purpose acquisition company (SPAC) incorporated in the Cayman Islands that raised capital through an IPO to identify and complete a merger or acquisition with a private operating business. The company does not generate operating revenue. It holds $172,500,000 in a Trust Account, invested in U.S. government securities with Equiniti Trust Company, LLC as trustee, at an initial value of $10.00 per Public Share (as of the IPO, November 2025). The company issued 17,250,000 Public Units on Nasdaq, with Class A ordinary shares, warrants, and rights trading separately under symbols CRAC, CRACW, and CRACR as of December 9, 2025. Crown Acquisition Sponsor LLC holds 4,312,500 Class B ordinary shares, representing 51.9% of total shares beneficially owned as of the 10-K filed March 27, 2026. The company was incorporated in April 2025. CEO Prashant Patel (age 51) has served as Chairman and Chief Executive Officer since inception, with prior experience in pharmaceutical and healthcare companies and SPAC advisory roles.

Revenue model

CRAC generates no operating revenue. Capital is held in a Trust Account funded by IPO gross proceeds and private placement proceeds totaling $172,500,000, invested in U.S. government securities. Economic return to shareholders depends entirely on the completion of a Business Combination within the Combination Period, after which trust funds are deployed as deal consideration.

Products and services

Public Units consisting of Class A ordinary shares, warrants (CRACW), and rights (CRACR). Each right entitles the holder to receive 0.20 of a Class A ordinary share upon consummation of a Business Combination. Upon consummation, 17,250,000 rights would convert into 3,450,000 Class A ordinary shares. Public Rights were valued at $0.4778 per right at IPO date, with aggregate fair value of $8,242,050.

Customers and end markets

Investors in SPAC units on Nasdaq. The ultimate end market depends on the target business selected for the Business Combination, which has not been identified as of the 10-K filed March 27, 2026. Management's stated expertise covers pharmaceutical, biotech, and healthcare industries, as well as capital markets transactions.

Value-chain role

SPAC sponsor and acquirer. The company acts as a publicly listed acquisition vehicle, sourcing a private target business and providing it a path to public markets via a Business Combination rather than a traditional IPO. Management has stated intent to be actively involved post-combination in strategic planning, capital allocation, and corporate governance.

Geographic exposure

Incorporated in the Cayman Islands. Sponsor address: Grand Cayman KY1-1111, Cayman Islands. Listed on Nasdaq (United States). No operating geographic footprint disclosed as of the 10-K filed March 27, 2026.

Source: SEC 10-K, filed 2026-03-27

Industry: Blank Checks